V. V. Kalaeva

V. V. Kalaeva

Auto-generated profile, based on publicly available information

V. V. Kalaeva

Research institute for complex issues of cardiovascular diseases; Kemerovo state medical university

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2017 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
VKV. N. Karetnikova
V. N. Karetnikova
VKV. V. Kalaeva
V. V. Kalaeva
MEMaria V. Evseeva
Maria V. Evseeva
ОГОльга Викторовна Груздева
Ольга Викторовна Груздева
MZM. V. Zykov
M. V. Zykov
OBOlga Barbarash
Olga Barbarash
Renal dysfunction (RD) in the acute phase of myocardial infarction (MI) is pivotal for the risk stratification of adverse long-term outcomes after myocardial infarction and, therefore, requires further study. Purpose. To determine the role of CKD and renal dysfunction (in the acute phase of MI) in the adverse long-term post-MI prognosis. Material and methods. 954 patients with ST-segment elevation myocardial infarction (STEMI) were enrolled in a registry study, performed in the period from 2008 to 2010 at the Kemerovo Cardiology Dispensary. All patients were assigned to two groups according to the presence of concomitant CKD. Serum creatinine levels were measured at the time of admission and on 10-12th days, with further calculation of glomerular filtration rate (GFR) using the CKD-EPI equation. Patients without CKD were assigned to Group I (n = 616 (64.5%), and STEMI patients with CKD to Group II (n=338 (35.4%). Observations during the three-year follow-up period were evaluated from the end-points. Results. The factors associated with mortality among patients with CKD were as follows: left ventricular ejection fraction (LVEF) < 40% at the time of admission (OR 2.1; 95% CI 1.0-4.4), signs of RD at the time of discharge (OR 2.5, 95% CI 1.0-5.9), non-performance of myocardial revascularization (OR 3.1, 95% CI 1.4-6.8). The long-term prognosis in the group of patients without CKD depended on the following factors: non-performance of PCI (OR 2.1, 95% CI 1.0-4.3), severe AHF (Killip class) (OR 3.5, 95% CI 1.9-6.7), LVEF < 40% (OR 2.0, 95% CI 1.0-3.8), and older age (OR 2.0, 95% CI 1.0-3.9). Conclusion. Renal dysfunction (regardless of the presence of CKD) diagnosed in the acute phase of MI as well as left ventricular dysfunction (EF < 40%) were found to affect long-term mortality risk in the post-MI period.

15 December 2018 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
VKV. N. Karetnikova
V. N. Karetnikova
VKV. V. Kalaeva
V. V. Kalaeva
MEM. V. Evseeva
M. V. Evseeva
ОГОльга Викторовна Груздева
Ольга Викторовна Груздева
ASA. A. Shilov
A. A. Shilov
OBOlga Barbarash
Olga Barbarash
Introduction. Currently, the importance of various factors in the acute period of myocardial infarction (MI) for the risk stratification of unfavourable course ofpost-infarction period is continued to be studied. Purpose. We aimed to identify the factors, affecting the formation of adverse outcomes of in-hospital and long-term postinfarction period in patients with ST-elevated MI (STEMI) undergone radiopaque interventions (ROI). Material and methods. The study included 954 STEMI patients admitted to the Kemerovo Cardiology Dispensary in the period from 2008 to 2010. Diagnostic coronary angiography was performed in 725 (76%) patients, and 557 (76.8%) of cases undergone myocardial revascularization (isolated balloon angioplasty, angioplasty with stenting). Results. The in-hospital mortality in STEMI patients was associated with the age older than 60 years (OR 2.4 95% CI 1.4-3.9, p<0.001), decrease in left ventricular ejection fraction (LVEF) less than 40% on admission (OR 1.9 95% CI 1.1-2.9) and contrast-induced nephropathy (CIN) (OR 1.9 95% CI 1.0-3.5). The area under the ROC-curve was 0.744 (0.693-0.796; р<0.001). Fatal outcomes within a year after MI were associated with the decrease of glomerular filtration rate (GFR) less than 60 ml/min/1.73 m (OR 1.4 95% CI 1.0-2.0), LVEF less than 40% (OR 1.7 95% CI 1.1-2.7), development of CIN (OR 2.3 95% CI 1.3-4.1). The area under the ROC-curve was 0.707 (0.665-0.749, р II on admission (OR 6.8 95% CI 2.1-21.8), 3.4-fold (OR 3.4 95% CI 1.1-11.0) in patients of the older age category (>60 years), 4.1-fold in development of CIN (OR 4.1 95% CI 1.1-14.3). The area under the ROC-curve was 0.744 (0.632-0.856, р=0.001). Conclusion. The independent risk factors of fatal outcome development within the in-hospital period in STEMI patients undergone ROI were: the age older than 60years, LVEF reduce less than 40% and the presence of CIN. Fatal outcomes within a year after MI were associated with GFR decrease less than 60 ml/min/1.73 m, LVEF less than 40% and CIN development, and within three years - AHF Killip class II and greater, age older than 60 years, as well as CIN after ROI.